Study on the Effects of Rifaximin on Stress and Fear Responses in Healthy Men
- Substances:Rifaximin
Belgium- Participants:18–64 years · Healthy volunteers
- Substances:Rifaximin
- Sponsor:UZ Leuven
Rare diseases
Investigational molecules
Locations
Back to Belgium2 092 clinical trials in Herentals, Belgium. Every trial is listed in the EU Clinical Trials Register and updated daily.
BelgiumStudy on the Effects of Naloxegol and Codeine on Opioid-Induced Constipation in Healthy Volunteers
BelgiumStudy on Pain and Usability of Rabies Vaccine Injection Techniques in Children Aged 4-14 Using Inactivated Rabies Virus (Strain Flury LEP)
BelgiumStudy on the Effectiveness of Durvalumab and BCG in Treating High-Risk, Non-Muscle Invasive Bladder Cancer in Patients New to BCG Treatment
BelgiumStudy on COVID-19 Prevention Using Sipavibart and Cilgavimab for Patients with Weakened Immune Systems
BelgiumStudy on the Safety and Immune Response of a 21-Valent Pneumococcal Conjugate Vaccine in Healthy Infants and Toddlers
BelgiumStudy on the 9vHPV Vaccine for Preventing Oral HPV Infections in Men Aged 20-45
BelgiumStudy Comparing Intradermal and Intramuscular Rabies Vaccine Doses in Adults
BelgiumStudy on the Effects of Doxycycline for Preventing Antibiotic Resistance in Patients with Bacterial STDs (Chlamydia, Gonorrhea, Syphilis)
BelgiumStudy on the Effects of Tobevibart and Elebsiran Compared to Bulevirtide for Patients with Chronic Hepatitis D Virus Infection
BelgiumStudy on Etrasimod Arginine for Patients with Ulcerative Colitis, Alopecia Areata, Atopic Dermatitis, and Eosinophilic Esophagitis
BelgiumStudy on the Effects of Liraglutide on Hunger and Digestion in Obese Patients
BelgiumThe busiest research cities in the country
What the registry says about research in the country
Innovative research focusing on follicular lymphoma and diffuse large B-cell lymphoma, evaluating novel therapeutic approaches against traditional treatments.
These trials aim to improve treatment outcomes for patients with various forms of lymphoma through targeted therapies.
Groundbreaking studies exploring early intervention in monoclonal gammopathy and smoldering multiple myeloma conditions.
Research focused on preventing progression to active multiple myeloma through innovative treatments.
Investigation of treatment strategies for rheumatoid arthritis, comparing conventional approaches with accelerated biological therapy access.
Comprehensive evaluation of various treatment approaches for better disease management outcomes.
Studies examining optimal approaches for PPI deprescription in patients with various gastrointestinal conditions including functional dyspepsia and reflux.
Focused on developing effective strategies for reducing long-term PPI use while maintaining symptom control.
Tell us about your condition – we search every trial in Europe and connect you with the right site.